Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
67,940.26 +2,182.09 (+3.32%) CMC Crypto 200
1,375.16 +44.56 (+3.35%)
Tandem Diabetes Care, Inc. (0M0F.L)
| Previous close | 41.88 |
| Open | 36.50 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 35.67 - 39.65 |
| 52-week range | 13.89 - 43.04 |
| Volume | |
| Avg. volume | 681 |
| Market cap | 2.245B |
| Beta (5Y monthly) | 1.29 |
| PE ratio (TTM) | 4.46 |
| EPS (TTM) | 0.09 |
| Earnings date | 01 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireTandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024
SAN DIEGO, July 11, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2024 results after the financial markets close on Thursday, August 1, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its second quarter 2024 financial and operating results.
ZacksTandem Diabetes (TNDM) Posts Positive Data for Tandem Mobi
Tandem Diabetes (TNDM) unveils survey results of the new Tandem Mobi insulin delivery system, underscoring its potential to significantly enhance the quality of life for people with diabetes
Business WireTandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions
SAN DIEGO, June 22, 2024--Tandem Diabetes Care today presented positive real-world data from a Tandem Mobi user satisfaction survey at the 2024 ADA Scientific Sessions.
